326 related articles for article (PubMed ID: 27416751)
1. Increased serum renalase in hemodialysis patients: is it related to left ventricular hypertrophy?
Oguz EG; Gursoy GK; Yayar O; Yildirim T; Cimen T; Bulut C; Eser B; Canbakan B; Yeter E; Ayli MD
Ren Fail; 2016 Sep; 38(8):1180-6. PubMed ID: 27416751
[TBL] [Abstract][Full Text] [Related]
2. Increased serum renalase in peritoneal dialysis patients: Is it related to cardiovascular disease risk?
Gok Oguz E; Akoglu H; Ulusal Okyay G; Karaveli Gursoy G; Yildirim T; Merhametsiz O; Cimen T; Canbakan B; Yeter E; Ayli MD
Nefrologia; 2017; 37(2):189-194. PubMed ID: 28160962
[TBL] [Abstract][Full Text] [Related]
3. Correlation between hypervolemia, left ventricular hypertrophy and fibroblast growth factor 23 in hemodialysis patients.
Unver S; Kavlak E; Gümüsel HK; Celikbilek F; Esertas K; Muftuoglu T; Kirilmaz A
Ren Fail; 2015 Jul; 37(6):951-6. PubMed ID: 26030798
[TBL] [Abstract][Full Text] [Related]
4. [Left ventricular hypertrophy in patients with chronic renal failure treated by hemodialysis].
Wanic-Kossowska M; Lehmann P; Czekalski S
Pol Arch Med Wewn; 2002 Jun; 107(6):539-46. PubMed ID: 12375575
[TBL] [Abstract][Full Text] [Related]
5. No association between deletion-type angiotensin-converting enzyme gene polymorphism and left-ventricular hypertrophy in hemodialysis patients.
Yildiz A; Akkaya V; Hatemi AC; Cine N; Tükek T; Görçin B; Demirel S; Türk S; Sever MS
Nephron; 2000 Feb; 84(2):130-5. PubMed ID: 10657713
[TBL] [Abstract][Full Text] [Related]
6. The relationship between adiponectin levels and proinflammatory cytokines and left ventricular mass in dialysis patients.
Ayerden Ebinç F; Ebinç H; Derici U; Aral A; Aybay C; Taçoy G; Koç E; Mutluay R; Altok Reis K; Erten Y; Arinsoy T; Sindel S
J Nephrol; 2009; 22(2):216-23. PubMed ID: 19384839
[TBL] [Abstract][Full Text] [Related]
7. Left ventricular hypertrophy and endothelial dysfunction in chronic kidney disease.
Poulikakos D; Ross L; Recio-Mayoral A; Cole D; Andoh J; Chitalia N; Sharma R; Carlos Kaski J; Banerjee D
Eur Heart J Cardiovasc Imaging; 2014 Jan; 15(1):56-61. PubMed ID: 23811493
[TBL] [Abstract][Full Text] [Related]
8. Fibroblast growth factor 23 and left ventricular mass index in maintenance hemodialysis patients: standard versus long nocturnal hemodialysis.
Knap B; Večerić-Haler Ž; Benedik M; Buturović-Ponikvar J; Ponikvar R; Bren AF
Ther Apher Dial; 2013 Aug; 17(4):407-11. PubMed ID: 23931880
[TBL] [Abstract][Full Text] [Related]
9. The role of mitofilin in left ventricular hypertrophy in hemodialysis patients.
Wu QS; He Q; He JQ; Chao J; Wang WY; Zhou Y; Lou JZ; Kong W; Chen JF
Ren Fail; 2018 Nov; 40(1):252-258. PubMed ID: 29619900
[TBL] [Abstract][Full Text] [Related]
10. Cross-sectional association of volume, blood pressures, and aortic stiffness with left ventricular mass in incident hemodialysis patients: the Predictors of Arrhythmic and Cardiovascular Risk in End-Stage Renal Disease (PACE) study.
Kim ED; Sozio SM; Estrella MM; Jaar BG; Shafi T; Meoni LA; Kao WH; Lima JA; Parekh RS
BMC Nephrol; 2015 Aug; 16():131. PubMed ID: 26249016
[TBL] [Abstract][Full Text] [Related]
11. Gender differences in mediators of left ventricular hypertrophy in dialysis patients.
Savage T; Giles M; Tomson CV; Raine AE
Clin Nephrol; 1998 Feb; 49(2):107-12. PubMed ID: 9524781
[TBL] [Abstract][Full Text] [Related]
12. Effects of short daily hemodialysis and extended standard hemodialysis on blood pressure and cardiac hypertrophy: a comparative study.
Fagugli RM; Pasini P; Pasticci F; Ciao G; Cicconi B; Buoncristiani U
J Nephrol; 2006; 19(1):77-83. PubMed ID: 16523430
[TBL] [Abstract][Full Text] [Related]
13. Circulating levels of renalase, norepinephrine, and dopamine in dialysis patients.
Zbroch E; Koc-Zorawska E; Malyszko J; Malyszko J; Mysliwiec M
Ren Fail; 2013; 35(5):673-9. PubMed ID: 23530612
[TBL] [Abstract][Full Text] [Related]
14. An association between inflammatory state and left ventricular hypertrophy in hemodialysis patients.
Erten Y; Tulmac M; Derici U; Pasaoglu H; Altok Reis K; Bali M; Arinsoy T; Cengel A; Sindel S
Ren Fail; 2005; 27(5):581-9. PubMed ID: 16152997
[TBL] [Abstract][Full Text] [Related]
15. The prevalence of left ventricular hypertrophy in Chinese hemodialysis patients is higher than that in peritoneal dialysis patients.
Tian JP; Wang T; Wang H; Cheng LT; Tian XK; Lindholm B; Axelsson J; Du FH
Ren Fail; 2008; 30(4):391-400. PubMed ID: 18569912
[TBL] [Abstract][Full Text] [Related]
16. Persistent elevation of C-reactive protein may predict cardiac hypertrophy and dysfunction in patients maintained on hemodialysis.
Kim BS; Jeon DS; Shin MJ; Kim YO; Song HC; Lee SH; Kim SY; Choi EJ; Chang YS; Bang BK
Am J Nephrol; 2005; 25(3):189-95. PubMed ID: 15863980
[TBL] [Abstract][Full Text] [Related]
17. Fibroblast growth factor 23 is associated with left ventricular hypertrophy, not with uremic vasculopathy in peritoneal dialysis patients.
Sarmento-Dias M; Santos-Araújo C; Poínhos R; Oliveira B; Silva IS; Silva LS; Sousa MJ; Correia F; Pestana M
Clin Nephrol; 2016 Mar; 85(3):135-41. PubMed ID: 26833300
[TBL] [Abstract][Full Text] [Related]
18. Hypoalbuminemia as a risk factor for progressive left-ventricular hypertrophy in hemodialysis patients.
Moon KH; Song IS; Yang WS; Shin YT; Kim SB; Song JK; Park JS
Am J Nephrol; 2000; 20(5):396-401. PubMed ID: 11092998
[TBL] [Abstract][Full Text] [Related]
19. Late referral to a nephrologist increases the risk of uremia-related cardiac hypertrophy in patients on hemodialysis.
Shin SJ; Kim HW; Chung S; Chung HW; Lee SJ; Kim YS; Bang BK; Chang YS; Park CW
Nephron Clin Pract; 2007; 107(4):c139-46. PubMed ID: 17957125
[TBL] [Abstract][Full Text] [Related]
20. The relationship of visfatin levels with insulin resistance and left ventricular hypertrophy in peritoneal dialysis patients.
Karakan S; Sezer S; Özdemir Acar FN; Haberal M
Ren Fail; 2012; 34(6):732-7. PubMed ID: 22503095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
